KMID : 0624620110440100659
|
|
BMB Reports 2011 Volume.44 No. 10 p.659 ~ p.664
|
|
Ginsenoside Rh2(S) induces the differentiation and mineralization of osteoblastic MC3T3-E1 cells through activation of PKD and p38 MAPK pathways
|
|
Kim Do-Yeon
Jung Mi-Song Park Young-Guk Yuan Hai Dan Quan Hai Yan Chung Sung-Hyun
|
|
Abstract
|
|
|
As part of the search for biologically active anti-osteoporotic agents that enhance differentiation and mineralization of osteoblastic MC3T3-E1 cells, we identified the ginsenoside Rh2(S), which is an active component in ginseng. Rh2(S) stimulates osteoblastic differentiation and mineralization, as manifested by the up-regulation of differentiation markers (alkaline phosphatase and osteogenic genes) and Alizarin Red staining, respectively. Rh2(S) activates p38 mitogen-activated protein kinase (MAPK) in time- and concentration-dependent manners, and Rh2(S)-induced differentiation and mineralization of osteoblastic cells were totally inhibited in the presence of the p38 MAPK inhibitor, SB203580. In addition, pretreatment with Go6976, a protein kinase D (PKD) inhibitor, significantly reversed the Rh2(S)-induced p38 MAPK activation, indicating that PKD might be an upstream kinase for p38 MAPK in MC3T3-E1 cells. Taken together, these results suggest that Rh2(S) induces the differentiation and mineralization of MC3T3-E1 cells through activation of PKD/p38 MAPK signaling pathways, and these findings provide a molecular basis for the osteogenic effect of Rh2(S).
|
|
KEYWORD
|
|
Differentiation and mineralization, Ginsenoside Rh2(S), MC3T3-E1 cells, Protein kinase D, p38 mitogen-activated protein kinase
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|